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Background: There is a bidirectional relationship between chronic low-grade inflammation and cancer. Inflammatory markers,
such as interleukin-6 (IL-6), have been associated with both the malignant transformation of epithelial cells and tumor progression,
thus linking low-grade inflammation with a higher risk of cancer and recurrence in the survival phase. Therefore, they are
considered valuable prognostic biomarkers. Knowing and finding appropriate primary prevention strategies to modify these
parameters is a major challenge in reducing the risk of cancer recurrence and increasing survival. Different therapeutic strategies
have shown efficacy in the modification of these and other biological parameters, but with contradictory results. There are
apparently no strategies in which telemedicine, and specifically mobile health (mHealth), are used as a means to potentially cause
biological changes.
Objective: The objectives of this study were to: (1) check whether it is feasible to find changes in inflammation biomarkers
through an mHealth strategy app as a delivery mechanism of an intervention to monitor energy balance; and (2) discover potential
predictors of change of these markers in breast cancer survivors (BCSs).
Methods: A prospective quasi-experimental pre-post study was conducted through an mHealth energy balance monitoring app
with 73 BCSs, defined as stage I-IIIA of breast cancer and at least six months from the completion of the adjuvant therapy.
Measurements included were biological salivary markers (IL-6 and C-reactive protein [CRP]), self-completed questionnaires
(the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, the user version of the
Mobile Application Rating Scale [uMARS] and an ad hoc clinical and sociodemographic questionnaire) and physical objective
measures (accelerometry, weight and height). In addition, using the logging data of the mHealth app, the rate of use (in days)
was recorded during the entire experimental phase of the study. Using Stata software, a paired two-tailed t test, Pearson and
Spearman correlations, and a stepwise multiple regression analysis were used to interpret the data.
Results: Analyzing changes in inflammatory biomarker concentrations after using the mHealth app, differences between
preassessment CRP (4899.04 pg/ml; SD 1085.25) and IL-6 (87.15 pg/ml; SD 33.59) and postassessment CRP (4221.24 pg/ml;
SD 911.55) and IL-6 (60.53 pg/ml; SD 36.31) showed a significant decrease in both markers, with a mean difference of –635.25
pg/ml (95% CI –935.65 to –334.85; P<.001) in CRP and –26.61 pg/ml (95% CI –42.51 to –10.71; P=.002) in IL-6. Stepwise
regression analyses revealed that changes in global quality of life, as well as uMARS score and hormonal therapy, were possible
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predictors of change in CRP concentration after using the mHealth app. In the same way, the type of tumor removal surgery
conducted, as well as changes in weight and pain score, were possible predictors of change in IL-6 concentration after using the
app.
Conclusions: In conclusion, through the results of this study, we hypothesize that there is a possible association between an
mHealth energy balance monitoring strategy and biological changes in BCSs. These changes could be explained by different
biopsychosocial parameters, such as the use of the application itself, quality of life, pain, type of tumor removal surgery, hormonal
treatment or obesity.
(J Med Internet Res 2019;21(8):e15062)  doi: 10.2196/15062
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Introduction
There is a bidirectional relationship between chronic low-grade
inflammation and breast cancer, as a tumor can produce an
inflammatory environment and therefore a systemic immune
response, but chronic inflammation can also both precede and
promote the development of cancer [1]. There is even talk of
considering inflammation to be an enabling feature of breast
cancer, or the seventh hallmark of the disease along with the
six hallmarks already identified by Hanahan and Weinberg [2,3].
Inflammation is a process, or bodily response, secondary to
infection or sudden injury, and it is associated with the activation
of various molecular mechanisms [4]. This response can be
local or systemic, depending on the severity, and both indicate
an imbalance of the metabolism of the affected tissues. This
metabolic imbalance in the lesion is produced by an increase
of immune cells as well as inflammatory parameters of great
clinical importance, such as C-reactive protein (CRP) and its
inducer interleukin-6 (IL-6) [4,5].
Once the inflammatory response ends, tissue metabolism is
normalized. If this process of remission is interrupted by some
circumstance, such as pathogens, toxins or other stimuli, healthy
tissue could be damaged and produce what is known as
persistent low-grade inflammation, or chronic inflammation
[6]. It is the result of an immune system that overreacts so that
the concentrations of inflammatory factors are higher than in a
healthy population [5]. This systemic and chronic inflammation
is widely associated with chronic diseases [6] and even
symptomatology, as there is a positive association between
increased levels of CRP and excess of adipose mass (excess
weight and obesity), which is a factor that could be potentially
modified with physical activity and diet [4,7]. Moreover,
inflammatory markers such as IL-6 have also been associated
with the malignant transformation of epithelial cells and tumor
progression, associating low-grade inflammation with a higher
risk of cancer and recurrence in the survival phase. Thus, these
factors are considered valuable prognostic biomarkers in the
population of those with cancer [1,8,9]. Therefore, knowing
and finding appropriate primary prevention strategies to modify
these parameters is a major challenge in the field, so as to reduce
the risk of cancer recurrence and increase survival.
Different therapeutic strategies have shown efficacy in the
modification of these and other biological parameters, but with
contradictory results. The beneficial effects of physical exercise
as a means of controlling low-grade inflammation have been
amply demonstrated [10,11], even in breast cancer survivors
(BCSs). A study conducted by Jones et al, in which they used
a physical exercise program in BCSs, found a significant
reduction of IL-6 [12]. Additional studies have evaluated other
strategies, such as manual therapy [13], tai chi [14], mindfulness
[15], or yoga [16], to reduce inflammation markers in different
cancer populations. However, scientific evidence about
strategies based on telemedicine are scarce, and they are
practically nonexistent for cancer. A study conducted by
Haggerty et al assessed two technology-based, 6-month, lifestyle
interventions (telemedicine or text messaging) in obese women
with endometrial hyperplasia, showing a reduction of some
biomarkers such as IL-6 after the intervention [17]. Another
study by Frank et al examined the effectiveness of telehealth
coaching promoting nutrition and exercise in soldiers, evaluating
biomarkers of bone health [18]. There are also some clinical
trial protocols with no published results at present [19-21].
Therefore, at the moment there are no strategies in which
telemedicine, and specifically mobile health (mHealth), are used
as a delivery mechanism for interventions that could cause
biological changes.
Low-grade inflammation is highly influenced by aspects such
as obesity, fatigue or a sedentary lifestyle [22-24], and its
relationship with chronic pathologies has been demonstrated.
However, the issue of association, or the factors that influence
its regulation through nonpharmacological and distance-based
intervention strategies, remain unresolved [6]. In the
biopsychosocial context that encompasses a subject with cancer,
promoting changes through mHealth strategies in psychological,
physical or social aspects is not entirely complicated (eg, quality
of life) [25]. However, biological parameters have a high
intersubject variability and are not usually addressed in these
types of studies [24]. Therefore, understanding what factors can
influence these parameters can help to develop mHealth-based
strategies, thus increasing patient empowerment in regard to
their health.
To the best of our knowledge, scientific evidence is scarce in
regard to mHealth-based strategies related to tracking
biomarkers of inflammation, and the importance of low-grade
inflammation in cancer recurrence has already been
demonstrated. Thus, the objectives of this study were to:
1. Check whether it is feasible to find changes in inflammation
biomarkers through an mHealth strategy as a delivery
mechanism of an intervention to monitor energy balance
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2. Discover potential predictors of change of these markers
in breast cancer survivors
Methods
Study Design, Participants, and Description of the
Mobile Health App
A prospective quasi-experimental pre-post study was conducted
through an mHealth app to monitor energy balance (BENECA
mHealth app) with 73 BCSs, defined as stage I-IIIA of breast
cancer and at least six months from the completion of adjuvant
therapy (only hormonal therapy was allowed). Participants were
recruited from the oncology units of San Cecili University
Hospital and Virgen de las Nieves University Hospital, both in
Granada, Spain, through their reference oncologists. All
participants received oral and written information about the
assessment protocols, mHealth app characteristics, and risks
and benefits of the study, and then written consent was obtained
from all of them. The Ethics Committee on Human Research
(CEIH) from Granada province, Spain, approved this study
(FIS, PI14-01627), which was performed in accordance with
the Declaration of Helsinki [26]. The inclusion and exclusion
criteria for this study are shown in Textbox 1.
After the initial assessment, all participants were invited to use
the mHealth app for two months. In summary, the mHealth app
was developed to help breast cancer survivors overcome energy
balance challenges and aimed to both motivate and sensitize
breast cancer survivors to adhere to fully personalized physical
exercise programs and nutritional plans, in compliance with the
international guidelines for cancer survivors. On first use, the
users of the app recorded their personal and anthropometric data
such as weight, height, age, and type of cancer. They were then
asked to record what they ate (every item) and what they did
(in terms of physical activity) the day before. Regarding food
intake, BENECA uses a dietary record questionnaire structured
with 6 consumption times. Regarding physical activity, patients
could record the activities they completed during the day
(intensity and duration) from 3 possible time periods (morning,
afternoon, and evening). BENECA only records those activities
that have a duration of at least 10 minutes.
Based on all this information, the mHealth app provided
automatic feedback about a person’s energy balance or
imbalance as well as nutritional information about what was
ingested. In the presence of energy imbalance, it provided useful
and simple tips to improve this imbalance. All these
straightforward, daily notifications were based on the guidelines
of the World Cancer Research Fund International [27], the
strategies for physical activity and diet in patients with cancer
from the American College of Sports Medicine [28], and the
recommendations of the American Cancer Society [29,30]. The
mHealth app was developed based on the theory of Learning,
on Goal-Setting Theory, and on Social Cognitive Theory so as
to include techniques such as reinforcement, facilitation,
self-monitoring, goal setting, feedback on performance and
reviewing goals, which have proven to be promising in
increasing physical activity in different populations [31,32].
The technical characteristics of the mobile application [33], as
well as validation of the energy balance monitoring system [34]
and its feasibility [35], have been previously published.
Participants were able to contact a researcher at any time via
WhatsApp, in case of technical problems or to discuss any
doubts they had. In addition, an online video tutorial was
available at any time.
Textbox 1. Inclusion and exclusion criteria.
Inclusion criteria:
• Between 30 and 75 years of age.
• Body mass index >25 kg/m2.
• Stage I-IIIA of breast cancer.
Exclusion criteria:
• No medical clearance to participate.
• Any physical health condition that prevents them from walking.
• Any physical or mental health condition that prevents them from participating in assessments.
• No access to any mobile device or tablet with an internet connection.
Outcomes Measures
To assess changes after use of the mHealth app, all
measurements were taken at baseline and 8-weeks after having
used it. Participants were called via phone for pre and
postassessments and invited to Cuidate Support Unit for
Oncology Patients, a clinical research center from the University
of Granada, Spain. Measurements taken included biological
markers, self-completed questionnaires, and both anthropometric
and physical objective measures. In addition, using the logging
data of the mHealth app, the rate of use (in days) was recorded
during the entire experimental phase of the study.
Biological Markers: Main Outcomes
Two salivary inflammatory markers were obtained: IL-6 and
CRP. Salivary biomarkers have previously demonstrated the
potential to be used for screening and research purposes [36].
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Sample Handling and Preparation: Salivary
Interleukin-6 and C-reactive Protein Concentrations
On the day of sample collection, the participants were informed
of the requirements: they were not allowed to eat, drink or brush
their teeth during the two hours prior to the collection, and they
were not allowed to visit the dentist 24 hours before sampling,
with the aim of reducing the risks of contamination. They were
also not allowed to consume alcohol during the 12 hours prior
to the collection of the sample, or to take acidic or high sugar
foods. The saliva sample collection was done between 10:00
and 11:30 in the morning, and an attempt was made to match
the time in the postassessment. Ten minutes before the collection
of the sample, participants were asked to rinse their mouths
with water. Saliva was collected by unstimulated passive drool
for 3 minutes using a polypropylene vial. Participants were
instructed to lean their heads forward, allowing the saliva to
accumulate on the floor of the mouth. Immediately after
collection, the sample was centrifuged at 3000-3500 rpm for
15 minutes (to remove mucins and other particles that might
interfere with the results), and then the supernatant was stored
in 200 μL tubes (total of 5 per participant). Finally, it was frozen
and stored at –80°C for no longer than 3 months.
Sample Analysis (Enzyme Linked Immunosorbent Assay
Procedures)
Once the sampling was completed, it was thawed completely
until reaching room temperature prior to the completion of the
solutions. The necessary sample was pipetted into dissolution
tubes, and the residual saliva not analyzed was frozen again.
The following enzyme linked immunosorbent assay (ELISA)
kits were chosen: the Salimetrics C-Reactive Protein ELISA
Kit (Kit number 1-3302, which is an enzyme-linked
immunoassay specifically designed and validated for the
quantitative measurement of salivary CRP), and the Salimetrics
IL-6 ELISA Kit (Kit number 1-3602, which is a sandwich
immunoassay specifically designed and validated for the
quantitative measurement of salivary IL-6). Both have been
designed and optimized for salivary research in humans. All
analyses and calculations were performed following the
manufacturer’s protocol, as described by Salimetrics. A total
of 15 μL and 60 μL of saliva were required for the analyses of
CRP and IL-6, respectively.
Once the reagents were prepared, we designed the plate where
100 μl of the samples were added, as well as the successive
dilutions of the standard of each marker that would be used for
the design of the standard curve. The sample was covered with
an adhesive and incubated for two hours at room temperature
before mixing at the mix plate at 500 rpm. Then, the plate was
washed 4 times with wash buffer by filling and emptying the
wells to remove the solution by either aspiration or plate
inversion. After washing, antibody conjugate solution was added
(100 μL/well) and then diluted in blocking buffer in a series of
twofold dilutions. Then the plate was sealed and incubated for
2 hours at room temperature. After the incubation, we repeated
the washing as described above. Once the wash was completed,
the substrate solution was added, and the plate was incubated
in the dark at room temperature for 30 minutes before then
mixing for 5 minutes on a plate rotator at 500 rpm. Then, we
stopped the reaction by adding the stop solution (50 μl). The
solution was mixed at the plate rotator for 3 minutes at 500 rpm.
The absorbance was then measured with a spectrophotometer
(Biotek ELx800) at 450 nm, according to kit manufacturers.
Results were compared with a standard curve that was
previously designed. All standards, controls and samples were
analyzed in duplicate.
Self-Completed Questionnaires
The European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire Core 30 (EORT
QLQ-C30) version 3.0 was used to measure quality of life of
the participants. It is a questionnaire specifically designed to
evaluate general aspects of quality of life of patients with cancer.
It is composed of a global scale of health status, five functional
scales (in which the higher the score, the higher the quality of
life reported) and eight symptom scales (in which the higher
the score, the greater the symptoms reported). This instrument
has shown adequate reliability [37,38].
The user version of the Mobile Application Rating Scale
(uMARS) was used to measure the satisfaction and quality of
usage of the mHealth app. This questionnaire is composed of
23 elements grouped into different sections, each of them
evaluated independently through a Likert scale of 1 to 5 points
(5 being excellent). Finally, the average score is calculated. This
scale has been validated and has proven to be simple, objective
and reliable [39].
An ad hoc questionnaire was used to collect clinical and
sociodemographic characteristics of participants, including the
stage of breast cancer, the type of tumor removal surgery, and
the medical treatment and hormonal therapy. The stage of breast
cancer could be I, II or III-A, the type of surgery was categorized
in increasing order according to invasion of the surgery method
(lumpectomy, quadrantectomy, unilateral mastectomy and
bilateral mastectomy), the medical treatment was either a
neoadjuvant or adjuvant treatment, and the hormonal therapy
was registered as either taking or not taking hormonal treatment,
as well as its typology.
Anthropometric and Physical Objective Measures
A preprogrammed triaxial accelerometer (ActiGraph GT3X+,
Pensacola, Florida) was used to collect data on participants'
physical activity over 8 consecutive days, together with a
questionnaire diary based on a previously published protocol
of use and analysis [40,41]. Only the records of more than 4
days, and of at least 10 hours per day, were included in the
analysis. Minutes of vigorous-to-moderate physical activity
(MVPA) were recorded.
Weight (kg) and height (cm) were measured with light clothing
and without shoes. Weight was measured using an electronic
scale (model SECA 869, Hamburg, Germany), and height was
measured in the Frankfort plane using a stadiometer (model
SECA 213).
Statistical Analysis
Measures of central tendency and dispersion were used for
continuous variables with a normal distribution. Categorical
variables were reported as proportions (%). The
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Kolmogorov-Smirnov test was used to check the normal
distribution of the data. To evaluate the differences in the
biological variables (CRP and IL-6) between baseline and after
8 weeks of use of the app, a paired two-tailed t test was used.
To analyze the correlation between the different variables,
Pearson and Spearman correlation were applied as appropriate.
In this correlation analysis, the change variable (difference
between postassessment and preassessment) was used with
quantitative variables: biological variables, quality of life (EORT
QLQ-C30 global score, fatigue and pain), satisfaction with the
app (uMARS global score), use of the app (in days), MVPA
(accelerometry) and weight. The change variable was also used
to measure changes in clinical variables such as type of tumor
removal surgery, stage of breast cancer, medical treatment and
hormonal therapy. Dispersion diagrams were used to study the
assumptions of normality, linearity and homoscedasticity. To
determine which variables could explain the variation in CRP
and IL-6 concentrations, a stepwise multiple regression analysis
was used. For the regression model with the dependent variable
of CRP, the score changes in general quality of life, hormonal
treatment, quality and satisfaction were considered independent
variables.
For the regression model with the dependent variable IL-6, type
of tumor removal surgery, and score changes in both perceived
pain and weight were considered independent variables. To be
included in the multiple regression analysis, the independent
variables had to have a correlation coefficient of r>0.20 between
the dependent variable and the independent variable, and they
had to be significant [42]. The possible collinearity between the
independent variables was studied, and then the final model
was validated using bootstrapping (the start-up method was
carried out with repeated samples of the same size to replace
the original samples). Two thousand repetitions were produced
to estimate the confidence intervals accelerated and corrected
for the starting bias. For statistical analyses, the level of
significance was set at P<.10. All analyses were performed
using the software Stata version 14 (Statacorp, College Station,
Texas). At least two experiments were performed in all assays.
Results
User Statistics and Clinical Characteristics
Participants were, on average, 51.35 (SD 8.58) years of age,
with a body mass index (BMI) of 28.86 (SD 8.58). A total of
64% of the BCSs listed their civil status as married and 21% as
single, with 41% having an educational status of higher
education and 31% having unfinished studies or primary school.
Table 1 summarizes clinical and sociodemographic participants’
characteristics.
Participants showed moderate quality of satisfaction (score
range=0-5) with the mHealth app (mean 3.71 points; SD 0.47
points), high app usage (mean 47.9 days; SD 10.40; max=56
days), and moderate to low scores (range 0-100) in general
quality of life (mean 57.6; SD 14.07), fatigue (mean 23.14; SD
15.46), and pain (mean 45.66; SD 25.91). Finally, mean weight
was 72.56 kg (SD 10.85 kg) and the mean MVPA was 47.27
(SD 23.41). Analyzing changes in inflammatory biomarker
concentrations after using the mHealth app, differences between
preassessment CRP (4899.04 pg/ml; SD 1085.25) and IL-6
(87.15 pg/ml; SD 33.59) and postassessment CRP (4221.24
pg/ml; SD 911.55) and IL-6 (60.53 pg/ml; SD 36.31) showed
a significant decrease in both of them, with a mean difference
of –635.25 pg/ml (95% CI –935.65 to –334.85; P<.001) in CRP
and –26.61 pg/ml (95% CI; –42.51 to –10.71; P=.002) in IL-6.
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Table 1. Participants’ demographics (N=73).
ParticipantsVariables
51.35 (8.58)Age (years), mean (SD)














17 (23.3)Unemployed by the disease









Medical treatment, n (%)
5 (6.9)None
6 (8.2)Radiation therapy alone
5 (6.9)Chemotherapy alone




Significant negative correlations were found between changes
in CRP concentration and EORT QLQ C30 general quality of
life (r=–0.281; P=.03), with hormonal therapy (r=–0.235;
P=.07), with uMARS score (r=–0.284; P=.02) and with mHealth
app usage (r=–0.263; P=.04). In addition, significant positive
correlations were found between change in IL-6 concentration
and EORT QLQ C30 pain (r=0.404; P=.01), with weight
(r=0.301; P=.06) and with type of tumor removal surgery
(r=0.311; P=.05).
In addition, significant correlations existed among the
independent variables (Table 2) but was only high between
uMARS score and mHealth usage (r=0.907; P<.001). Therefore,
considering multicollinearity possible (defined as r>0.70), only
uMARS score was included in the regression analyses.
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aΔ: change between postassessment and preassessment.
bCRP: C-reactive protein.
cIL-6: interleukin-6.
dC30: EORT QLQ C-30 questionnaire.
eQoL: quality of life.
fMVPA: minutes of vigorous-to-moderate physical activity.
gBC: breast cancer.




Stepwise regression analyses revealed that changes in global
quality of life, as well as uMARS score and hormonal therapy,
were possible predictors of change in CRP concentration after
using the app (Table 3). In the same way, the type of tumor
removal surgery, as well as changes in weight and pain score,
were possible predictors of change in IL-6 concentration after
using the app (Table 4). For both tables, r2 denotes the variability
of change in biomarker concentration explained by the predictors
in percent.
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Table 3. Summary of stepwise regression analyses to determine predictors of change in C-reactive protein concentration (r2=19%).
P valuetStandardized
coefficients, β




.22–1.25–0.155–110.304–272.774 to 52.166–286.447 to 65.839–110.304Hormonal therapy
.02–2.39–0.289–728.785–1396.04 to –61.533–1338.675 to –118.898–728.786uMARSd score
.04–2.11–0.261–18.605–37.022 to –0.177–36.253 to –0.945–18.601ΔeGlobal QoLf
aβ: regression coefficient.
bBCA: bias-corrected and accelerated.
cNot applicable.
duMARS: user version of the mobile application rating scale.
eΔ: change between postassessment and preassessment.
fQoL: quality of life.
Table 4. Summary of stepwise regression analyses to determine predictors of change in IL-6 concentration (r2=26%).
P valuetStandardized
coefficients, β




.201.30.1948.22–5.383; 21.821–4.604; 21.048.219Type of surgery
.081.580.234.455–0.582; 9.495–1.263; 10.1764.456ΔdWeight
.032.210.3280.6670.003; 1.330.054; 1.2790.667ΔPain score
aβ: regression coefficient.
bBCA: bias-corrected and accelerated.
cNot applicable.
dΔ: change between postassessment and preassessment.
Discussion
The objective of this study was to determine the preliminary
results of the possible association between the use of an mHealth
strategy app as a delivery mechanism to monitor energy balance
in cancer and the reduction of systemic inflammation markers,
as well as to suggest possible predictors of this change. Current
findings suggest that after two months of use of the app, a
significant reduction of these markers can be observed. Thus,
there could be a possible association between the two. In
addition, the change in weight, pain and quality of life, as well
as the type of tumor removal surgery, hormone therapy and the
uMARS score, can have a contribution in the changes found in
the concentrations of CRP and IL-6.
A system of monitoring energy balance through an mHealth
app seems to reduce the biological parameters of systemic
inflammation (CRP and IL-6). Our results suggest that after
two months of use of the mHealth app, based on the monitoring
of energy balance (in terms of diet and physical activity), the
concentration of CRP and IL-6 are significantly reduced in
BCSs. In fact, this change has a moderate effect size in CRP
(Cohen d=–0.640; 95% CI –0.985 to –0.293) and a high effect
size in IL-6 (Cohen d=–0.805; 95% CI –1.225 to –0.379). A
study by Skogstad et al was the only one found with a design
similar to ours, as it used a virtual internet physical activity
motivation strategy in which some biological parameters were
measured [43]. In this study, participants were included in a
motivational physical activity program in which they measured
their steps using a wrist-band accelerometer. However, unlike
our study, no differences were found in CRP concentration after
the intervention, perhaps because their study target population
were healthy workers without pathology. The effect size reported
for both our biomarkers supports the hypothesis that these
changes are not due to time, but it is important to remark that
the quasi-experimental pre-post design of our study does not
allow us to affirm that the changes found are only attributable
to the use of the app. Therefore, a controlled and randomized
clinical trial should be carried out in the future.
Biological parameters of systemic inflammation can be mediated
or modified by lifestyles changes such as physical activity and
diet [4,6,7]. This study is the first to examine clinical and
anthropometric factors that affect changes in these biological
parameters, after using a mobile strategy to monitor energy
balance in breast cancer survivors. Because rehabilitation
strategies focus on face-to-face or distance physical activity and
diet programs, understanding the potential determinants of
reducing inflammation markers can help design more effective
intervention strategies.
The results of our study show that possible moderators of a
reduction in CRP concentration include not receiving hormonal
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therapy, as well as having higher satisfaction and changes in
quality of life (the higher quality of life change, the lower the
CRP concentration). The role of estrogen in inflammation is
poorly understood, the mechanism is not well studied, and its
relationship is very complex [44], and different studies show
contradictory results depending on different pathologies, with
some showing they are associated with an inflammatory activity,
while others show a proinflammatory role [44]. The differences
found in pre and postmenopausal women suggest that the
peripheral production of estrogens plays an important role in
these differences [44-47]. Our results provide new evidence in
this regard, since not having received hormone therapy may be
a predictor of a greater reduction in CRP concentration in female
survivors of breast cancer. However, estrogen’s relationship
with quality of life has been considered from another point of
view. We understand that it is not that a higher perception of
quality of life is a predictor of a reduction of proinflammatory
markers but rather the other way around, that the diminished
inflammatory state is associated with an increase in the quality
of life [48,49]. Ultimately, our results suggest a higher score in
uMARS as a predictor of the change in CRP concentration. In
addition, there is a strong association between satisfaction and
quality with the amount of time spent on the mHealth app. If
women with the highest score in uMARS use the mHealth app
more, then the reduction in inflammatory markers could be due
to the direct relationship caused by a healthier lifestyle [6,50,51].
The results of our study also show possible moderators of the
reduction in IL-6 include the type of tumor removal surgery
(less invasive surgery), as well as changes in both weight and
pain (the greater the reduction of these factors, the greater the
reduction of IL-6). These results are consistent with the known
bidirectional relationship between obesity and low-grade
inflammation, which contributes to systemic metabolic
dysfunction that is associated with obesity-linked disorders [4].
In the same way, an inflammatory reaction is also mediated by
the classic cardinal signs of inflammation (eg, pain) [52].
Therefore, it is logical to think that a reduction in pain reported
by breast cancer survivors can be a predictor of a reduction in
IL-6 concentration such as that observed in our results. Finally,
there is a lot of scientific evidence to support the use of
minimally invasive surgical techniques since they don’t raise
inflammatory reactants as much, and these findings may support
the relationship between IL-6 and the type of tumor removal
surgery found in our results [53-56].
It is worth highlighting some strengths and limitations of the
present study. The main strength lies in the nature of the study.
To the best of our knowledge, this is the first study that proposes
a mobile strategy to monitor energy balance as a mediator in
the reduction of proinflammatory markers in BCSs. If future
research supports our results, we will have found another support
strategy for cancer survivors that is low cost and accessible to
everyone and which could reduce markers highly related to the
risk of recurrence. However, there are also many limitations to
be noted. The main limitation lies in the design of the study, as
well as the sample size, which prevents us from speaking in
terms of causality and effectiveness. In addition, the r2 obtained
in the multiple regression models was low. However, we must
not forget that we are trying to explain biological parameters
with nonbiological variables. Our results may support the
biopsychosocial model, since it shows how biology can be
modified through these variables. Other biological parameters
that can justify the rest of the variability that has remained to
be explained should be taken into account in the future.
In conclusion, through the results of this study, we hypothesize
that there is a possible association between an mHealth energy
balance monitoring strategy app and biological changes in BCSs.
These changes could be explained by different biopsychosocial
parameters such as the use of the application itself, quality of
life, pain, type of tumor removal surgery, hormonal treatment
or obesity. Future studies should be carried out with a specific
focus on all these biological parameters, and with an appropriate
study design, to support these findings.
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